FDA updates providers on lymphoma risk associated with breast implants
The Food and Drug Administration yesterday updated health care providers about a type of lymphoma associated with breast implants and recommendations to inform patients about the risk and report, evaluate and treat the condition. Providers, patients and manufacturers have reported 457 cases of breast implant-associated anaplastic large cell lymphoma since 2010, including nine deaths. For more information, visit www.fda.gov.
Related News Articles
Headline
With the advent of technology and integrated clinics, Henry Ford Health System is leading the way in serving its growing communities. In this conversation,…
Perspective
Seventy years ago, George Brock Chisholm, M.D., the first director-general of the World Health Organization, famously stated that “without mental health there…
Blog
According to the CDC, 80% of pregnancy-related deaths can be prevented; that’s a 20% increase from previous years. Know why?
That’s actually the theme for…
#HealthCareInnovation Blog
By Marie Cleary-Fishman
Five years ago, a national effort began to ensure that health care for older adult patients is “age friendly.” This initiative — Age…
Headline
The Centers for Medicare & Medicaid Services and Centers for Disease Control and Prevention yesterday published a final rule that would update 1992…
News
In this case study, learn how New Jersey-based Hackensack Meridian Health successfully integrated behavioral health services across the health system by…